Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV)

Catalog No:
MBL-TS-M032-1
$1,470.00

Formerly Catalog No.: TB-M032-1

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence CLGGLLTMV
Sequence Location 426-434
MHC Allele A*02:01

Documents & Links

Documents & Links for Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV)
Datasheet Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV) Datasheet

Documents & Links for Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV)
Datasheet Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV) Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence CLGGLLTMV
Sequence Location 426-434
MHC Allele A*02:01

Documents & Links

Documents & Links for Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV)
Datasheet Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV) Datasheet

Documents & Links for Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV)
Datasheet Tetramer/PE - HLA-A*02:01 EBV LMP2 (426-434) (CLGGLLTMV) Datasheet